Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04557826 · ClinicalTrials.gov registry record · NA
Acute Safety and Acceptability Study of Experimental Device RD19 for Protection From Human Respiratory Disease Pathogens
A NA study, sponsored by EmitBio.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT04557826 is a NA study that has completed, run by EmitBio. The registered enrollment target is 25 participants.
The verdict
NCT04557826, a NA study, has completed, sponsored by EmitBio.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
This first-in-man (FIM) phase I study will evaluate the acute safety, tolerability, and acceptability of the investigational RD19 device among 25 healthy volunteers between the age of 18 and 45.
Interventions
- DEVICE RD19
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2020-08-31 |
| Est. Completion | 2020-12-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04557826
The ClinicalTrials.gov registry entry for NCT04557826 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is EmitBio, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RD19 is the first listed.
NCT04557826 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04557826 about?
NCT04557826 is a clinical study titled "Acute Safety and Acceptability Study of Experimental Device RD19 for Protection From Human Respiratory Disease Pathogens". This first-in-man (FIM) phase I study will evaluate the acute safety, tolerability, and acceptability of the investigational RD19 device among 25 healthy volunteers between the age of 18 and 45.
What is the current status of trial NCT04557826?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2020-08-31. Estimated completion is 2020-12-07.
What interventions are being tested in trial NCT04557826?
The interventions under investigation include: RD19 (DEVICE).
Who is sponsoring clinical trial NCT04557826?
This trial is sponsored by EmitBio, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.